Pharmaceutical companies have been criticized before for encouraging those in the medical field to broaden the criteria used for prescribing certain medications while effectively ignoring the potential, and often horrendous, side effects of taking that drug. Psychiatric drugs may be the group of drugs that most people think of when they think about this issue.
However, there is a “new” kid on the block that is seeing massive numbers of people taking the drug but very few people talking about its dangers. And what is this offender?
Approximately 25% of all Americans over the age of 45 are taking a statin drug, and new guidelines issued by the US National Heart, Lung, and Bood Institute would recommend that 483,500 people between aged 17-21 begin taking statin drugs. Yes, there is a lot of money flowing out for statin drugs.
While statin drugs may have positive uses, we have to wonder how many statin users understand the risks of what they are ingesting. For example, a study published in Atherosclerosis, a medical journal, showed “a 52 percent increased prevalence and extent of calcified coronary plaque content compared to non-users [of statin drugs].” [emphasis added]
Statins have also been linked to increased risk for cancer, increased risk for diabetes by increased insulin resistance, and increased risk of heart failure. If that isn’t counter-productive enough for you, understand that statins cause increases in blood sugar levels and promote Alzheimer’s, high blood pressure, and heart attacks.
And all of this is because the establishment medical field dominated by pharmaceutical companies with a profit motive to create problems to solve and point to problems that they can solve, even if that problem isn’t really the issue. For example, overall cholesterol levels aren’t so much the issue; bad cholesterol levels are. Unfortunately, too many people don’t realize that low good cholesterol levels cause health problems, too.
Cholesterol levels are easy to target because a profit can be made by “solving” that problem. But, while statins are sold on the idea of preventing heart problems, it is actually refined carbs that are responsible for heart disease. As noted on mercola.com:
“Dietary fat is believed to have the greatest influence on cardiovascular risk through elevated concentrations of low density lipoprotein (LDL) cholesterol. But the reduction in LDL cholesterol from reducing saturated fat intake appears to be specific to large, buoyant type A LDL particles, when it is the small dense type B particles – responsive to carbohydrate intake – that are implicated in cardiovascular disease.”
So, essentially, the American public has been sold a drug that they don’t need to fix a problem that isn’t really a problem, and this was probably done because the real problem can’t be solved by a profitable pharmaceutical solution.
In other words, consider cutting your intake of refined carbs to solve the problem that statins claim to address.